A phase I/II trial of induction cisplatin and docetaxel followed by concomitant docetaxel/radiotherapy with subcutaneous amifostine for locally advanced squamous cell carcinoma of the head and neck

Status: Completed

Phase of Trial: Phase I/II

Latest Information Update: 07 Feb 2019

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

14 Feb 2011 Aventis Pharmaceuticals as company and lead trial centres identified as reported by ClinicalTrials.gov.
10 Nov 2006 New trial record.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com